Keyword Connections

target of rapamycin (tor) serine-threonine kinases

Journals

1

1 cancer

Research Groups

0

No Research Group Connected

Bibliographies

1

1 A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.